MAPK6 (Mitogen-Activated Protein Kinase 6), also known as ERK3 (Extracellular Signal-Regulated Kinase 3), is an atypical member of the MAP kinase family. Unlike classical MAP kinases such as ERK1/2, MAPK6 has distinct regulatory mechanisms and cellular functions. It plays critical roles in cell division, differentiation, stress responses, and synaptic plasticity. In the nervous system, MAPK6 is involved in neurodevelopment, learning and memory, and has been increasingly recognized for its contributions to neurodegenerative processes. This page provides comprehensive coverage of MAPK6's molecular function, disease associations, expression patterns, and its emerging role in Alzheimer's disease ([AD](/diseases/alzheimers-disease)), [Parkinson's disease](/diseases/parkinsons-disease), and related neurodegenerative disorders.
MAPK6 (Mitogen-Activated Protein Kinase 6), also known as ERK3 (Extracellular Signal-Regulated Kinase 3), is an atypical member of the MAP kinase family. Unlike classical MAP kinases such as ERK1/2, MAPK6 has distinct regulatory mechanisms and cellular functions. It plays critical roles in cell division, differentiation, stress responses, and synaptic plasticity. In the nervous system, MAPK6 is involved in neurodevelopment, learning and memory, and has been increasingly recognized for its contributions to neurodegenerative processes. This page provides comprehensive coverage of MAPK6's molecular function, disease associations, expression patterns, and its emerging role in Alzheimer's disease ([AD](/diseases/alzheimers-disease)), [Parkinson's disease](/diseases/parkinsons-disease), and related neurodegenerative disorders.
MAPK6 is a serine/threonine protein kinase that functions as part of the MAP kinase signaling cascade. While it shares structural homology with other MAP kinases, MAPK6 exhibits unique features including its lack of classical activation loop phosphorylation sites and its regulation through nuclear-cytoplasmic shuttling. Research over the past two decades has revealed that MAPK6 is involved in diverse cellular processes beyond its initially characterized roles in cell cycle progression, including neuronal differentiation, synaptic plasticity, and stress response pathways. The kinase has emerged as a potential therapeutic target in neurodegeneration due to its regulation of key processes including tau phosphorylation, neuroinflammation, and neuronal survival.
<div class="infobox infobox-gene">
<div class="infobox-header">MAPK6 — Mitogen-Activated Protein Kinase 6</div>
MAPK6 (ERK3) is an atypical MAP kinase involved in cell division, differentiation, stress responses, and synaptic plasticity. It plays critical roles in neurodevelopment and has been increasingly recognized for its contributions to neurodegenerative processes.
<table class="infobox-table">
<tr><th>Gene Symbol</th><td>MAPK6</td></tr>
<tr><th>Full Name</th><td>Mitogen-Activated Protein Kinase 6</td></tr>
<tr><th>Alternative Names</th><td>ERK3, PRKM6</td></tr>
<tr><th>Chromosomal Location</th><td>15q21.2</td></tr>
<tr><th>NCBI Gene ID</th><td>[5603](https://www.ncbi.nlm.nih.gov/gene/5603)</td></tr>
<tr><th>OMIM</th><td>[616431](https://www.omim.org/entry/616431)</td></tr>
<tr><th>Ensembl ID</th><td>[ENSG00000170048](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000170048)</td></tr>
<tr><th>UniProt</th><td>[Q9Y4G2](https://www.uniprot.org/uniprot/Q9Y4G2)</td></tr>
<tr><th>Protein Length</th><td>721 amino acids</td></tr>
<tr><th>Protein Kinase Domain</th><td>Serine/Threonine protein kinase, MAPK family</td></tr>
<tr><th>Associated Diseases</th><td>Alzheimer's disease, Parkinson's disease, neurodevelopmental disorders, cancer</td></tr>
</table>
</div>
MAPK6 encodes mitogen-activated protein kinase 6, an atypical member of the MAP kinase family. Unlike classical MAP kinases, MAPK6 is regulated primarily through interactions with MAPKAP kinases (MK2/MK3) rather than through dual phosphorylation of the activation loop. MAPK6 participates in diverse signaling pathways controlling cell proliferation, differentiation, stress responses, and synaptic plasticity. In the brain, MAPK6 is expressed in neurons and glial cells where it modulates neuronal development, cognitive function, and responses to neurotoxic stress. Dysregulation of MAPK6 signaling has been implicated in the pathogenesis of Alzheimer's disease, Parkinson's disease, and other neurodegenerative conditions, making it a subject of ongoing research interest.
MAPK6 is a serine/threonine protein kinase that catalyzes the transfer of phosphate groups from ATP to serine or threonine residues on substrate proteins. The canonical kinase domain of MAPK6 spans residues 46-330 and contains the characteristic motifs required for ATP binding and catalysis. Unlike classical MAP kinases such as ERK1/2, MAPK6 lacks the TXY activation motif in its activation loop; instead, it is constitutively active as a kinase and is regulated primarily through:
The primary downstream targets of MAPK6 are MAPKAP kinase 2 (MK2, also known as MAPKAPK2) and MAPKAP kinase 3 (MK3). The MAPK6-MK2/3 module regulates:
MAPK6 phosphorylates several known substrates:
MAPK6 occupies a unique position in the MAP kinase signaling network. While it can be activated by certain extracellular stimuli, it is not typically integrated into the classic RAS-RAF-MEK-ERK1/2 cascade. Instead, MAPK6:
In neurons, MAPK6 interfaces with several pathways implicated in neurodegeneration:
MAPK6 exhibits a broad expression pattern across tissues, with particularly high levels in the brain:
Highest expression is observed in brain, with moderate levels in:
MAPK6 is predominantly cytoplasmic but undergoes nuclear-cytoplasmic shuttling. In unstimulated cells, it is distributed throughout the cytoplasm. Upon certain stimuli or stress, MAPK6 can translocate to the nucleus where it may phosphorylate nuclear substrates.
Multiple lines of evidence link MAPK6 to Alzheimer's disease pathogenesis:
In Parkinson's disease context:
| Interaction Partner | Relationship | Functional Significance |
|---------------------|--------------|------------------------|
| MAPKAPK2 (MK2) | Substrate/activator | Primary downstream kinase in signaling module |
| MAPKAPK3 (MK3) | Substrate/activator | Secondary downstream kinase |
| HSP90AA1 | Co-chaperone | Required for MAPK6 stability and function |
| 14-3-3 proteins | Binding partner | Regulates subcellular localization |
| Cyclin-dependent kinases | Cross-talk | Cell cycle regulation |
| p38 MAPK | Parallel pathway | Stress response signaling |
| AKT1 | Cross-talk | Survival signaling modulation |
Zebrafish have been used to study MAPK6 function in neural development, revealing requirements for proper brain morphogenesis and neuronal differentiation.
While MAPK6 is not a high-penetrance disease gene for monogenic neurodegeneration, polymorphisms in the MAPK6 gene have been associated with:
MAPK6 represents a potential therapeutic target for neurodegeneration: